Komori
OncoTherapy Science (4564) · PolicyRestated

Ensuring transparency through legal compliance and prompt, accurate disclosure

First written in FY2016. 2 of 3 entries say "Restated". Latest entry: FY2018.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20182016: 120162017: 120172018: 12018
Same theme, other companies
Continuous Strengthening of Corporate Governance and Internal Control SystemsA theme 969 companies write about · 4 as a headwind · 1069 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 185 companies compared. The sentences above are computed from all 185.Comparing 200 of the theme's 1075 threads.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for OncoTherapy Science yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Ensuring transparency through legal compliance and prompt, accurate disclosure | OncoTherapy Science,Inc. (4564) | Komori